Published :
Report ID:
Pages :
Format :
The market for hemostasis valves is expected to grow at a CAGR of around 5.6% from 2020 to 2027 and expected to reach the market value of around US$ 212.5 Bn by 2027.
Hemostasis is the appropriate physiologic response to vascular injury that provides prompt control of blood loss and hemostasis valves are used in minimizing blood loss and optimizing control of diagnostic and interventional devices.
Market Dynamics
The increasing number of interventional procedures along with the rising demand for advanced hemostasis devices by hospitals and clinicians that aid in better treatment and meet procedural demands is supporting the market value. The technological advancement in hemostasis valves by manufacturers that meet professional preferences is additionally supporting the market value. The increasing number of accident cases across the globe is supporting the market growth because hemostasis valves that have simple functionality can maximize performance, and minimize leakage. Additionally, rising health concern among individuals coupled with the increasing demand for hemostasis valves for various diagnostic and therapeutic producers is contributing to the market value.
On the other side, complex manufacturing processes and technical glitch are the factors projected to hamper the growth over the forecast period from 2020 to 2027.
Hemostasis Valve Y-Connectors dominated the market with maximum share
In 2019, the Hemostasis Valve Y-Connectors segment accounted for the major share (%) in the market by type. Moreover, the double Y-connector hemostasis valves segment is projected to experience the fastest growth with major CAGR (%) over the forecast period from 2020 to 2027.
Interventional is leading the global hemostasis valves market
Based on application, interventional segment is leading the market with maximum share in 2019 and the segment is also projected to continue with its dominance over the forecast timeframe from 2020 to 2027. The increasing number of interventional procedures across the globe is majorly supporting the market value.
The market research study on “Hemostasis Valves Market– Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 – 2027”, offers a detailed insights into the global Hemostasis Valves market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report provides insights into the global Hemostasis Valves market, its type, application, end-user, and major geographic regions. The report covers basic development policies and layouts of technology development processes. Secondly, the report covers global Hemostasis Valves market size and volume, and segment markets by type, application, end-user, and geography along with the information on companies operating in the market. The Hemostasis Valves market analysis is provided for major regional markets including North America, Europe, Asia Pacific, Latin America and Middle East and Africa. For each region, the market size and volume for different segments have been covered under the scope of the report.
North America is leading the global market with major share
In 2019, North America is leading the global Hemostasis Valves market with maximum share. The region is particularly gaining growth on account of its advanced healthcare infrastructure. The presence of major players including Abbott, ARGON MEDICAL, DeRoyal Industries, Inc., and Isla Lab Products among others in the regional market is additionally supporting the market value. Moreover, the region is also projected to maintain its dominance over the forecast period.
The players profiled in the report include Abbott, ARGON MEDICAL, B. Braun Melsungen AG, Boston Scientific Corporation, DeRoyal Industries, Inc., EXCEL MEDICAL PRODUCTS, Freudenberg Medical, Frisch Medical, Galt Medical Corp., Isla Lab Products, Merit Medical Systems, SCITECH, SCW Medicath Ltd, Shenzhen Antmed Co.,Ltd., Teleflex Incorporated, TERUMO CORPORATION, and VascuTech Medical.
Market Segmentation
Market By Type
Hemostasis Valve Y-Connectors
Double Y-Connector Hemostasis Valves
One-Handed Hemostasis Valves
Others
Market By Application
Diagnostic
Interventional
Market By End-User
Hospitals
Ambulatory Surgical Centers
Others
Market By Geography
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
Hemostasis is the appropriate physiologic response to vascular injury that provides prompt control of blood loss and hemostasis valves are used in minimizing blood loss and optimizing control of diagnostic and interventional devices.
The report provides insights into the global Hemostasis Valves market, its type, application, end-user, and major geographic regions.
The hemostasis valves market value is anticipated to be worth around US$ 212.5 Bn in 2027.
The CAGR of the global hemostasis valves market from 2020-2027 is above 5.6%.
The key players operating in hemostasis valves market such as Abbott, ARGON MEDICAL, B. Braun Melsungen AG, Boston Scientific Corporation, DeRoyal Industries, Inc., EXCEL MEDICAL PRODUCTS, Freudenberg Medical, Frisch Medical, Galt Medical Corp., Isla Lab Products, Merit Medical Systems, SCITECH, SCW Medicath Ltd, Shenzhen Antmed Co.,Ltd., Teleflex Incorporated, TERUMO CORPORATION, and VascuTech Medical.
The Hemostasis Valves market analysis is provided for major regional markets including North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
The types of hemostasis valves such as, Hemostasis Valve Y-Connectors, Double Y-Connector Hemostasis Valves, One-Handed Hemostasis Valves and others.
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date